Evaluation of Clinical Outcomes With the V-Go Wearable Insulin Delivery Device in Patients With Type 2 Diabetes-Reference-Cited by-同舟云学术

Evaluation of Clinical Outcomes With the V-Go Wearable Insulin Delivery Device in Patients With Type 2 Diabetes

Published:2021-07-01 Issue:3 Volume:39 Page:297-303
ISSN:0891-8929
Container-title:Clinical Diabetes
language:en
Short-container-title:

Author:

Meade Lisa T.¹²^ORCID,Battise Dawn¹³

Affiliation:

1. Wingate University, Hickory, NC

2. Catawba Valley Health System, Hickory, NC

3. Cabarrus Family Medicine–Harrisburg, Wingate, NC

Abstract

Uncontrolled type 2 diabetes can lead to a multitude of health complications. Insulin therapy is recommended when patients are unable to reach their A1C goal with oral or noninsulin injectable diabetes medications. This study evaluated the clinical benefits of switching from multiple daily insulin injections to a wearable insulin delivery device (V-Go). A retrospective chart review was conducted on 44 patients who received prescriptions for the V-Go at two family medicine offices. Investigators found a significant reduction in A1C and daily insulin requirements with no impact on weight or BMI.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/clinical/article-pdf/39/3/297/627077/diaclincd200094.pdf

Reference34 articles.

1. Centers for Disease Control and Prevention . National Diabetes Statistics Report, 2020: Estimates of Diabetes and Its Burden in the United States. Available from https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed 22 September 2020

2. 1. Improving care and promoting health in populations: Standards of Medical Care in Diabetes—2020;American Diabetes Association;Diabetes Care,2020

3. 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes—2020;American Diabetes Association;Diabetes Care,2020

4. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm: 2020 executive summary;Garber;Endocr Pract,2020

5. Insights into optimal basal insulin titration in type 2 diabetes: results of a quantitative survey;Berard;Diabetes Obes Metab,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Newer Outpatient Diabetes Therapies and Technologies;Medical Clinics of North America;2024-09

2. Recent progress of microneedles in transdermal immunotherapy: A review;International Journal of Pharmaceutics;2024-09

3. Advancements in Insulin Pumps: A Comprehensive Exploration of Insulin Pump Systems, Technologies, and Future Directions;Pharmaceutics;2024-07-15

4. Identifying patients with type 2 diabetes who might benefit from insulin pump therapy: Literature review, clinical opportunities, potential benefits and challenges;Diabetes, Obesity and Metabolism;2023-04-13

5. Continuous Subcutaneous Insulin Infusions: Closing the Loop;The Journal of Clinical Endocrinology & Metabolism;2022-12-27